Ledger.Open graph →

SEC Form D · filed May 28, 2025

GT Biopharma, Inc

Offering

$20.0M

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Charles Casamento · SAN FRANCISCO, CADirector Alan Urban · SAN FRANCISCO, CAExec Michael Breen · SAN FRANCISCO, CAExec · Director Andrew Ritter · SAN FRANCISCO, CADirector Hilary Kramer · SAN FRANCISCO, CADirector Charles Casamento · SAN FRANCISCO, CADirector Hilary Kramer · SAN FRANCISCO, CADirector Alan Urban · SAN FRANCISCO, CAExec Michael Breen · SAN FRANCISCO, CAExec · Director Andrew Ritter · SAN FRANCISCO, CADirector Walt Krumbholz · Seattle, WAExec · Director Maggie Weiland · Seattle, WAExec Lisa Dow · Seattle, WADirector Turner Waskom · Seattle, WADirector Carl Seip · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗